Núñez, Y.; Garcia-León, A.; Falgà s, A.; Serna, N.; Sánchez-GarcÃa, L.; Garrido, A.; Sierra, J.; Gallardo, A.; Unzueta, U.; Vázquez, E.;
et al. T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics 2023, 15, 727.
https://doi.org/10.3390/pharmaceutics15030727
AMA Style
Núñez Y, Garcia-León A, Falgà s A, Serna N, Sánchez-GarcÃa L, Garrido A, Sierra J, Gallardo A, Unzueta U, Vázquez E,
et al. T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics. 2023; 15(3):727.
https://doi.org/10.3390/pharmaceutics15030727
Chicago/Turabian Style
Núñez, Yáiza, Annabel Garcia-León, Aïda Falgà s, Naroa Serna, Laura Sánchez-GarcÃa, Ana Garrido, Jorge Sierra, Alberto Gallardo, Ugutz Unzueta, Esther Vázquez,
and et al. 2023. "T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo" Pharmaceutics 15, no. 3: 727.
https://doi.org/10.3390/pharmaceutics15030727
APA Style
Núñez, Y., Garcia-León, A., Falgà s, A., Serna, N., Sánchez-GarcÃa, L., Garrido, A., Sierra, J., Gallardo, A., Unzueta, U., Vázquez, E., Villaverde, A., Mangues, R., & Casanova, I.
(2023). T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics, 15(3), 727.
https://doi.org/10.3390/pharmaceutics15030727
